KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Amgen (AMGN) Shares Outstanding (2016 - 2026)

Amgen has reported Shares Outstanding over the past 18 years, most recently at $539.7 million for Q1 2026.

  • For Q1 2026, Shares Outstanding changed 0.37% year-over-year to $539.7 million; the TTM value through Mar 2026 reached $539.7 million, changed 0.37%, while the annual FY2025 figure was $538.8 million, 0.35% changed from the prior year.
  • Shares Outstanding for Q1 2026 was $539.7 million at Amgen, roughly flat from $538.8 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $539.7 million in Q1 2026 and troughed at $533.5 million in Q3 2022.
  • A 5-year average of $536.3 million and a median of $536.4 million in 2024 define the central range for Shares Outstanding.
  • Biggest five-year swings in Shares Outstanding: fell 7.14% in 2022 and later grew 0.45% in 2024.
  • Year by year, Shares Outstanding stood at $534.0 million in 2022, then increased by 0.26% to $535.4 million in 2023, then increased by 0.28% to $536.9 million in 2024, then grew by 0.35% to $538.8 million in 2025, then grew by 0.17% to $539.7 million in 2026.
  • Business Quant data shows Shares Outstanding for AMGN at $539.7 million in Q1 2026, $538.8 million in Q4 2025, and $538.5 million in Q3 2025.